Custom service
Recombinant Peptide Synthesis
Produce peptides recombinantly when chemistry is not the right tool
The service is built around E. coli expression cassette design. Depending on the molecule we may move to fusion-tag strategy (SUMO, GST, His) or tag-cleavage and polishing workflow to improve stability, loading or yield, and every batch is released with recombinant peptide with expression and purity data.
Because Recombinant Peptide Synthesis projects usually feed a downstream assay or preclinical study, we lock the release specification early — purity, identity and functional readouts are agreed at quotation, not discovered at delivery.
Peptides too long or disulfide-rich for chemistry
Isotopically labeled constructs for NMR
Short peptides where synthesis is faster and cleaner
Sequences where a recombinant expression route is objectively cheaper and faster
Release specification is fixed at quotation: standard >95% by HPLC, >98% for assay-critical material. Long chains (>60 residues) are additionally confirmed by MS/MS sequence coverage, and truncated-deletion species are quantified, not just summarized.
Service Highlights
- E. coli expression cassette design as the default route, with fusion-tag strategy (SUMO, GST, His) held as a proven fallback
- Tag-cleavage and polishing workflow worked into the design where the application requires it
- Sequence difficulty analysis (aggregation risk, motif hazards) is done before synthesis, and the route is chosen around it
- Analytical confirmation of every intermediate before the final release
- Microwave-assisted coupling and double-coupling are applied automatically where the sequence demands them
- Recombinant peptide with expression and purity data delivered with a complete conjugation or synthesis certificate
How the work runs
Sequence analysis
Recombinant Peptide Synthesis is analyzed for aggregation risk, motif hazards and puri?cation difficulty before a route is quoted.
Route selection
Fmoc solid-phase, fragment ligation or hybrid solution-phase is selected and documented.
Assembly
The chain is built with E. coli expression cassette design applied where the sequence demands it, with double-coupling at hazard sites.
Cleavage & crude QC
Crude material is characterized so purification targets are set on data, not hope.
Purification
RP-HPLC (and ion-exchange where needed) delivers the agreed purity; fractions are pooled on MS confirmation.
Release
Recombinant peptide with expression and purity data is documented with the full analytical package and released.
Specifications & timeline
- Turnaround
- 6–10 weeks
- Typical scale
- 0.1 mg – 10 g per sequence
- Chemistry options
- E. coli expression cassette design; fusion-tag strategy (SUMO, GST, His); tag-cleavage and polishing workflow
- Deliverable
- Recombinant peptide with expression and purity data
- QC package
- HPLC purity, ESI/MALDI MS, MS/MS confirmation for long chains
- Shipping
- Ambient with desiccant; blue ice for modified or sensitive peptides
Related Products
- Recombinant ProteinsGrowth factors, cytokines and antigens produced across E. coli, yeast, insect and mammalian hosts — over 10,000 items on the shelf and ready to move.
- Native ProteinsIsolated directly from natural sources, preserving native post-translational modifications and conformational epitopes that recombinant systems can miss.
- Monoclonal AntibodiesRecombinant and hybridoma clones characterised for Western blot, IHC, immunofluorescence, ELISA and flow cytometry — application data included.
Next step
Tell us the target, we will tell you what is feasible
Send the sequence, assay format and sensitivity you need. You will get a technical assessment — recommended platform, timeline and the risks worth knowing before you commit budget.